Shares of Aptevo Therapeutics (NASDAQ: AVO) have surged over 38% premarket on Thursday following news that shareholder Tang Capital has offered to buy the remaining shares of the company.
Life sciences focused investment firm Tang Capital already owns a 42.5% stake in Aptevo and has made an offer of $50 per share in cash to acquire the remaining shares.
In a letter to the board at Aptevo, Tang said:
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“Our proposal is based on 4.8 million total shares outstanding, assuming the exercise of all remaining warrants from the March 2019 public offering, and is subject to confirmatory due diligence that would be conducted pursuant to a customary non-disclosure agreement.”
The company already has holdings in Odonate Therapeutics, Rocket Pharmaceuticals, Heron Therapeutics, and Biohaven Pharmaceutical Holdings.
Tang said that they do not expect an agreement with Aptevo to contain any financing conditions and they are excited about the company’s prospects.
Shares of Aptevo are currently trading at $48.90 premarket after a rise of 38.17%. So far this year its share price has gained 268.23% in value, although it has fallen 26.82% in the last week.
Wall Street analysts surveyed by TipRanks see a potential 87.91% upside in the stock based on Wednesday’s close of $35.39, setting a medium price target of $66.50.
PEOPLE WHO READ THIS ALSO VIEWED:
